2018
DOI: 10.23822/eurannaci.1764-1489.23
|View full text |Cite
|
Sign up to set email alerts
|

Cutaneous drug reactions to antiepileptic drugs and relation with HLA alleles in the Turkish population

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
3
0
2

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 13 publications
0
3
0
2
Order By: Relevance
“…Each antiepileptic was analyzed separately. For carbamazepine, there were 42 case–control studies [14–54] and 7 meta-analyses [41,55–60]. For lamotrigine, there were 30 case–control studies [16,18,20,28,36,41,44,48,51,61–74] and three meta-analyses [68,70,72].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Each antiepileptic was analyzed separately. For carbamazepine, there were 42 case–control studies [14–54] and 7 meta-analyses [41,55–60]. For lamotrigine, there were 30 case–control studies [16,18,20,28,36,41,44,48,51,61–74] and three meta-analyses [68,70,72].…”
Section: Resultsmentioning
confidence: 99%
“…For carbamazepine, there were 42 case–control studies [14–54] and 7 meta-analyses [41,55–60]. For lamotrigine, there were 30 case–control studies [16,18,20,28,36,41,44,48,51,61–74] and three meta-analyses [68,70,72]. As all the case–control studies for carbamazepine and lamotrigine were included in the meta-analyses, we only analyzed the results of the meta-analyses.…”
Section: Resultsmentioning
confidence: 99%
“…For Carbamazepine, there were 42 case-control studies(11-14)(15-52)and 7 meta analyses (39,(53)(54)(55)(56)(57)(58). For Lamotrigine, there were 30 case-control studies (13,15,17,26,34,39,42,46,49,(59)(60)(61)(62)(63)(64)(65)(66)(67)(68)(69)(70)(71)(72) and 3 meta-analyses (66,68,70). As all the case-control studies for Carbamazepine and Lamotrigine were included in the meta-analyses, we only analysed the results of the meta-analyses.…”
Section: Study Characteristicsmentioning
confidence: 99%
“…Genetik çalışmalar, HLA lokuslarının aşağıdaki hastalıklar ile ilişkisi için pek çok kanıt sağlamıştır (Messemaker et al, 2015;Büyüköztürk et al, 2018;Yarman et al, 2007;Oguz et al, 2004;Blackwell et al, 2009;Chen et al, 2003; 1. Otoimmün ve enflamatuar hastalıklar: Akut ön üveit, alopesi areata, astım, atopik dermatit, egzama, romatoid artrit, behçet hastalığı, çölyak hastalığı, kollajen kolit, polianjitis granülomatoz (Wegener granülomatoz), ankilozan spondilit, sistemik lupus eritematozus, vaskülit, tip 1 diyabet, crohn hastalığı, ülseratif kolit, dermatomiyozit ve graves hastalığı (Messemaker et al, 2015;Büyüköztürk et al, 2018;Yarman et al, 2007;Oguz et al, 2004) 2. Enfeksiyonlar: Önceki çalışmalarda, HLA ve HLA dışı lokuslarının çoğu, enfeksiyona karşı bağışıklık yanıtlarının genetik bileşenleri veya aşılama ve kalıcı antikor gelişimi ile yakından ilişkili bulunmuştur.…”
Section: İmmünogenetik Ve Kalıtsal Multifaktöriyel Hastalıklar Riskiunclassified
“…Araştırmacılar spesifik HLA alellerinin, insan immün yetmezlik virüsü tip 1, insan T hücresi lösemi virüsü tip 1, hepatit C virüsü ve SARS-CoV gibi viral enfeksiyonların orataya çıkışı ve bazı allelerin bu hastalıklara yatkınlık oluşturduğunu göstermişlerdir (Blackwell et al, 2009;Chen et al, 2003; 3. Olumsuz ilaç reaksiyonları: Stevens-Johnson sendromu/toksik epidermal nekroliz (karbamazepin), agranülositoz (klozapin), pankreatit (tiyopürin) ve karaciğer hasarı (terbinafin, fenofibrat, tiklopidin ve pazopanib) (Büyüköztürk et al, 2018) 4. Aşılara yanıt: Hepatit B…”
Section: İmmünogenetik Ve Kalıtsal Multifaktöriyel Hastalıklar Riskiunclassified